scholarly journals The future of long‐term monitoring following catheter and surgical intervention for atrial fibrillation

2020 ◽  
Author(s):  
Graham Lohrmann ◽  
Rod Passman
Keyword(s):  
Atrial Fibrillation ◽  
Surgical Intervention ◽  
The Future ◽  
Long Term Monitoring ◽  
Term Monitoring

First clinical experience with the wearable cardiac rhythm long-term monitoring cardioskin device

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
P Guedeney ◽  
J Silvain ◽  
F Hidden-Lucet ◽  
C Maupain ◽  
S Dinanian ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Clinical Practice ◽  
Cardiac Rhythm ◽  
Cardiac Monitoring ◽  
Funding Source ◽  
Single Center ◽  
Long Term Monitoring ◽  
Monitoring Devices ◽  
Term Monitoring

Abstract Background There are only limited options for long-term cardiac monitoring devices readily available in clinical practice for outpatients. Holter monitoring devices are limited by the uncomfort of wires and patches, the small number of leads for analysis, the quality of recordings or the monitoring duration while insertable cardiac monitors are costly and exposed to potential local complication. Purpose To describe a single center experience with a novel wearable device for cardiac rhythm monitoring. Methods The Cardioskin™ system is a patch-free, wire-free, wearable device with rechargeable batteries that provides a high quality 15-lead electrocardiogram monitoring over 1 month (Figure 1). Data are sent using a mobile application downloaded in the patient smartphone to a central Corelab where they can be interpreted by an expert and/or the prescribing physician. An alarm signal is readily available within the Cardioskin™ device, to allow patients to indicate the presence of symptoms. In this single center retrospective registry, we provide a first report of the use of this novel device in real world practice, with indication and duration of cardiac monitoring left at the physicans “discretion”. Results From January 2019 to December 2019, the Cardioskin™ system was prescribed in 60 patients for an overall median duration of 26.5 (14–32) days. The mean age of the patients was 45±12.2 years and 24 (40%) were male. Indications for cardiac monitoring were post-Stroke, palpitation, syncope and cardiomyopathy assessment in 56%, 30%, 7% and 7% of the cases, respectively. A sustained (>30 seconds) supraventricular tachycardia was detected in 4 cases, including one case of atrial fibrillation, two case of atrial tachycardia and on case of junctional tachycardia. Unsustained ventricular tachycardia and atrial fibrillation burst were detected in another 2 cases (Figure 1). There was no reported case of skin irritation by the Cardioskin™ system or abrupt interruption of the monitoring by the patients. Conclusion The Cardioskin™ system is a novel, discreet and comfortable cardiac rhythm wearable long-term monitoring device which can be used in clinical practice for broad diagnostic indications. Figure 1. Cardioskin system Funding Acknowledgement Type of funding source: Public Institution(s). Main funding source(s): ACTION coeur

Optimism and opportunities for conservation physiology in the Anthropocene

2020 ◽  
pp. 319-330
Author(s):  
Steven J. Cooke ◽  
Christine L. Madliger ◽  
Jordanna N. Bergman ◽  
Vivian M. Nguyen ◽  
Sean J. Landsman ◽  
...  
Keyword(s):  
Case Studies ◽  
Conservation Physiology ◽  
Success Stories ◽  
The Future ◽  
Long Term Monitoring ◽  
Term Monitoring

We discuss 12 themes that emerged from the set of case studies comprising the text, namely: (1) mechanisms matter for conservation; (2) physiology is just one source of knowledge; (3) physiology and behaviour are intertwined; (4) new tools and technologies should be embraced; (5) physiology can be valuable in captive settings; (6) conservation physiology extends across scales; (7) physiology can be incorporated into long-term monitoring programmes; (8) conservation physiology is applicable to invertebrates; (9) non-imperilled species deserve attention; (10) successful application is increased by co-production; (11) sharing success stories is important; and (12) findings should be communicated across a variety of platforms. We end the chapter with a discussion of some of the challenges currently being faced in the discipline, and with a message of optimism for the future.

Atrial Arrhythmia Burden on Long-Term Monitoring in Asymptomatic Patients Late After Atrial Fibrillation Ablation

2012 ◽  
Vol 110 (6) ◽  
pp. 840-844 ◽  
Author(s):  
Roger A. Winkle ◽  
R. Hardwin Mead ◽  
Gregory Engel ◽  
Melissa H. Kong ◽  
Rob A. Patrawala
Keyword(s):  
Atrial Fibrillation ◽  
Atrial Arrhythmia ◽  
Atrial Fibrillation Ablation ◽  
Asymptomatic Patients ◽  
Long Term Monitoring ◽  
Term Monitoring

scholarly journals Contemplating the future: Acting now on long-term monitoring to answer 2050's questions

2015 ◽  
Vol 40 (3) ◽  
pp. 213-224 ◽  
Author(s):  
David B. Lindenmayer ◽  
Emma L. Burns ◽  
Philip Tennant ◽  
Chris R. Dickman ◽  
Peter T. Green ◽  
...  
Keyword(s):  
The Future ◽  
Long Term Monitoring ◽  
Term Monitoring

Forty-five Years and Counting: Reflections from the Palomarin Field Station on the Contribution of Long-Term Monitoring and Recommendations for the Future

The Condor ◽  
2011 ◽  
Vol 113 (4) ◽  
pp. 713-723 ◽  
Author(s):  
Elizabeth L. Porzig ◽  
Kristen E. Dybala ◽  
Thomas Gardali ◽  
Grant Ballard ◽  
Geoffrey R. Geupel ◽  
...  
Keyword(s):  
Field Station ◽  
The Future ◽  
Long Term Monitoring ◽  
Term Monitoring

scholarly journals Supraventricular Runs in 7-Day Holter Monitoring Are Related to Increased Incidence of Atrial Fibrillation in a 3-Year Follow-Up of Cryptogenic Stroke Patients Free from Arrhythmia in a 24 h-Holter

2021 ◽  
Vol 8 (7) ◽  
pp. 81
Author(s):  
Andrzej Kułach ◽  
Milena Dewerenda ◽  
Michał Majewski ◽  
Anetta Lasek-Bal ◽  
Zbigniew Gąsior
Keyword(s):  
Atrial Fibrillation ◽  
Cryptogenic Stroke ◽  
Holter Monitoring ◽  
Ecg Monitoring ◽  
Stroke Patients ◽  
Long Term Monitoring ◽  
In Cis ◽  
Term Monitoring

Introduction: Silent atrial fibrillation (AF) is a common cause of cryptogenic ischemic stroke (CIS). The 24-h-Holter is insufficient to reveal an occult arrhythmic cause of stroke and the strategy to select the patients for long-term monitoring is missing. Objectives: The aim of the study was to evaluate 7-day-Holter monitoring to identify cases with the arrhythmic cause of stroke in CIS patients in whom 24-h-Holter was free from arrhythmia, and to assess the relation between supraventricular (SV) runs in baseline Holter and the incidence of AF in a 3-year follow-up period. Methods: 78 patients (aged 60 ± 9 years, 45 males) with CIS and no arrhythmic findings in 24-h-Holter were enrolled. All patients had 7-day-Holter monitoring after stroke and were followed up for 36 months, and then 7-day Holter was repeated. We assessed SV runs (≥5 QRS) in the initial 7-day Holter and analyzed the relation of the findings with clinical characteristics of novel AF episodes revealed early after stroke and during a 3-year follow-up. Results: Baseline 7-day-Holter revealed SV runs in 36% of patients and AF in 9% of cases. During a 3-year follow-up, 8 additional cases were confirmed, both in standard care and in repeated Holter (a total of 19% of AF cases). There was no difference with regard to CHADS2VASc score (3.6 ± 1.1 vs. 3.4 ± 1.5; p = NS) and left atrium parameters between patients with SV runs and the non-arrhythmic group. Patients with SV runs had a higher incidence of AF both after stroke and in a 3-year follow-up (46% vs. 4%, RR 11.6, p < 0.001). In 8 cases, patent foramen ovale was detected during follow-up. Conclusions: A strategy of baseline 7-day-Holter monitoring after stroke allows for disclosing SV runs in every third case and AF in 9% of stroke survivors. Patients with SV runs have a higher incidence of AF (RR 11.6, p < 0.001) and should be considered for extended continuous ECG monitoring.

Sign in / Sign up

Export Citation Format

Share Document